Equity Mates Investing Podcast cover image

Three Aussie stocks that break the boring stereotype - David Wilson | First Sentier Investors

Equity Mates Investing Podcast

00:00

ResMed: A Sleep Apnea Success Story

This chapter explores the growth and resilience of ResMed, an Australian leader in sleep apnea treatment devices, which has secured over 60% of the global market. It highlights market opportunities amid undiagnosed cases and contrasts the perceptions of Australian and American investors on ResMed's risks and prospects.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app